LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Hoffman and Abeloff's Hematology-Oncology Review
- 1st Edition - November 16, 2017
- Editor: Claudine Isaacs
- Language: English
- Paperback ISBN:9 7 8 - 0 - 3 2 3 - 4 2 9 7 5 - 7
For those preparing for certification or recertification in hematology or oncology, Hoffman and Abeloff's Hematology-Oncology Review is a single-volume source of authoritative, u… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteFor those preparing for certification or recertification in hematology or oncology, Hoffman and Abeloff's Hematology-Oncology Review is a single-volume source of authoritative, up-to-date exam preparation. This unique question and answer review helps you succeed on today’s board exams with more than 1,000 board-style questions, answers, and rationales; comprehensive coverage of essential exam topics, and online practice tests.
- Includes 1,000+ board-style questions with answers and rationales explaining both correct and incorrect answers.
- Features three online practice tests per specialty that follow the ABIM exams blueprint, ensuring that complex content is delivered in easily digestible segments for more efficient review.
- Covers a broad range of topics compiled by experts in hematology and oncology, including cancer biology and genomics, immunotherapy, hematologic malignancies, solid tumor malignancies, non-malignant hematology, and supportive care.
- Uniquely designed as both a standalone review and a study companion to Abeloff’s Clinical Oncology and Hematology: Basic Principles and Practice.
- Expert Consult™ eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.
Isaacs: Hoffman and Abeloff's Hematology-Oncology Review
1. Cancer biology and Genomics
2. Tumor Immunology
3. Anti-Cancer Therapies
SECTION 1: Chemotherapy
SECTION 2: Immunotherapy, antibodies, vaccines and pathway inhibitors
4. Clinical Trial Design and Ethics
5. Hereditary Cancer Syndromes
HEMATOLOGIC MALIGNANCIES
6. Acute Myeloid Leukemia and Myelodysplastic Syndrome
7. Myeloproliferative Disorders
8. Chronic Lymphocytic Leukemia, Hairy Cell Leukemia, and other Chronic Lymphoproliferative Disorders
9: Hodgkin lymphoma
10. Non-Hodgkin Lymphoma
11. Multiple myeloma and other plasma cell dyscrasias
12. T cell and NK cell neoplasms and other lymphoid malignancies
13. Hematopoeietic Cell Transplantation
SOLID TUMOR MALIGNANCIES
14. Breast cancer
a: Early Stage Breast Cancer
b: Metastatic breast cancer
e. Premalignant breast conditions and in situ disease
15. Lung Cancer
a: Non-small cell lung cancerb: Small cell lung cancer
16. Other Thoracic Malignancies
a: Mesothelioma
b: Thymoma and thymic cancer
17. Head and Neck cancer
18 : Esophageal Cancer
19: Gastric cancer
20: Pancreatic cancer
21: Colorectal cancer and Anal Cancer
22: Hepatobiliary cancer
23: Neuroendocrine, small bowel and appendiceal malignancies
24. Prostate cancer
25. Bladder and other urothelial cancers
26. Renal Carcinomas
27. Germ cell tumors
28. Gynecological Malignancies
- Ovarian Cancer and Fallopian Tube Cancer
- Cancer of the Cervix, Uterus, Vagina, Vulva and Gestational Choriocarcinoma
29. Melanoma and other skin cancers
30. Bone and soft tissue sarcoma
31.Cancer of unknown primary site
32. .
Malignancies of the Central Nervous Systema. Primary
b. Metastatic
NONMALIGNANT HEMATOLOGIC CONDITIONS
33. Coagulation
34. Hematopoietic System
1: Hematopoietic System Disorders RBC or iron
35. Transfusion Medicine
SURVIVORSHIP AND END OF LIFE CARE
Chapter 36. Supportive Care
- No. of pages: 400
- Language: English
- Edition: 1
- Published: November 16, 2017
- Imprint: Elsevier
- Paperback ISBN: 9780323429757
CI
Claudine Isaacs
Affiliations and expertise
Co-Director, Breast Cancer Program, Medical Director, Fisher Center for Hereditary Cancer and Clinical Genomics Research, Lombardi, Comprehensive Cancer Center, Georgetown University Medical Center